Related references
Note: Only part of the references are listed.A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
Michael Schwendinger et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
Weldy Bonilla et al.
CELL REPORTS MEDICINE (2021)
Prevention of tuberculosis in macaques after intravenous BCG immunization
Patricia A. Darrah et al.
NATURE (2020)
Dynamics of Mycobacterium tuberculosis Ag85B Revealed by a Sensitive Enzyme-Linked Immunosorbent Assay
Joel D. Ernst et al.
MBIO (2019)
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
Floriane Auderset et al.
FRONTIERS IN IMMUNOLOGY (2019)
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
D. R. Tait et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages
Jason D. Yang et al.
PLOS PATHOGENS (2018)
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector
Mark R. Schleiss et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design
Mohsen Karbalaei Zadeh Babaki et al.
MICROBIAL PATHOGENESIS (2017)
Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
Pablo Penaloza MacMaster et al.
VACCINE (2017)
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
Stefan H. E. Kaufmann et al.
FRONTIERS IN IMMUNOLOGY (2017)
TB vaccine development and the End TB Strategy: importance and current status
Helen A. Fletcher et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2016)
Protective Efficacy of Individual CD8+ T Cell Specificities in Chronic Viral Infection
Susan Johnson et al.
JOURNAL OF IMMUNOLOGY (2015)
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
Rami Sommerstein et al.
PLOS PATHOGENS (2015)
Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics
Niels Peter H. Knudsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
What is the efficiency of BCG?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2014)
Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
A. Roy et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates
Lukas Flatz et al.
JOURNAL OF VIROLOGY (2012)
The recombinant tuberculosis vaccine rBCG ΔureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells
Maura Farinacci et al.
VACCINE (2012)
Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
Martin O. C. Ota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity
Lukas Flatz et al.
NATURE MEDICINE (2010)
A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
Crystal Y. Chen et al.
PLOS PATHOGENS (2009)
Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis
Hans-Willi Mittruecker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rescue of the prototypic Arenavirus LCMV entirely from plasmid
Ana B. Sanchez et al.
VIROLOGY (2006)
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA
L Flatz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin
L Grode et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: Efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy
J Dietrich et al.
JOURNAL OF IMMUNOLOGY (2005)
Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein
DD Pinschewer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory
D Homann et al.
NATURE MEDICINE (2001)
Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice
AO Sousa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
